A significantly elevated concentration was also found in NSCLC patients compared with the HP group for IL-6 (p = 0.023) and TGF-β (p < 0.001), and all controls for IL-6 (p = 0.025) (Fig 4B and 4C). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.